Mikhail Blagosklonny works as the Professor of Oncology at the Roswell Park Institute of Cancer. Dr. Mikhail Blagosklonny has centered his work on studying on anti-aging and the possibility of preventing healthy cells from being cancerous. He has carried out several research studies that focus on cancer therapies. He is popular for his work in TOR signaling during aging. The research concentrates on the relationship that exists between Rapamycin and extending one’s lifespan. Apart from his research activities on impactjournals.com, Dr. Blagosklonny has become highly active in publishing several academic journals. One of the leading journals where he publishes his work is Oncotarget.
Blagosklonny earned his education from First State Pavlov Medical University situated at St. Peterburg in Russia. He received his M.D. in the field of internal medicine and a Ph.D. in the area of cardiology research and experimental medicine on Impactjournals.com. After his studies, he moved to the United States where he became a professor at the New York Medical School located in Valhalla in 2002. He took a position as the senior scientist at the Ordway Research Institute. He held the position until the year 2009. He got appointed to become the Professor of Oncology.
Since moving to Rowell Park Cancer Institution, Blagosklonny research work has focused on cancer and finding therapies that separate healthy cells from cancer infected cells. He wants to create a mechanism that should kill cancer cells and leave the healthy cells. He has developed several theories and treatment options for aging and anti-aging medications. Mikhail Blagosklonny has since come up with several publications that relate to clinical trials, oncology, and hematology. One of his recent books was in the research of how Dual Inhibitors reduce cellular division. Source: https://www.linkedin.com/in/mikhail-blagosklonny-91abb531
Mikhail Blagosklonny has made several other publications that seek to find the relationship between longevity and calorie restriction. He created a purported immortal being known as Koschei who used anti-aging drugs. Koschei lived in Northern Europe, ate very little, and possessed a bony body. The publication discussed the use of other drugs to extending life through calorie restriction. His research saw him use Rapamycin to investigation fat gain prevention. He carried out the study of weight gain in rats.